search

You must select a month AND year to filter.

 
  • FDA 'Black Box' Warning on Blood Thinner Plavix
  • March 18, 2010
  • The Food and Drug Administration (FDA) announced a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.

  • Information on How the New ESA REMS Program Will Affect MDS Patients
  • March 11, 2010
  • On March 24, the Food and Drug Administration (FDA) will require that all drugs called erythropoiesis-stimulating agents (ESAs) be prescribed and used under a risk management program, known as a risk evaluation and mitigation strategy (REMS), to ensure the safe use of these drugs.

  • March is DVT Awareness Month
  • March 9, 2010
  • ASH continues to work with several advocacy coalitions and the Department of Health and Human Services on efforts to increase public awareness of DVT as a major public health problem.

  • Persons With Quebec Platelet Disorder Have a Tandem Duplication of PLAU
  • March 8, 2010
  • Quebec platelet disorder (QPD) is an autosomal dominant bleedingdisorder linked to a region on chromosome 10 that includes PLAU, the urokinase plasminogen activator gene. QPD increases urokinase plasminogen activator mRNA levels, particularly during megakaryocyte differentiation, without altering expression of flanking genes.

  • ASH Announces 2010 Scholar Award Winners
  • March 4, 2010
  • (WASHINGTON) – The American Society of Hematology (ASH) announces the 2010 recipients of its Scholar Awards. The program is designed to support hematologists who have chosen a career in research by providing partial salary or other support during that critical period required for completion of training and achievement of status as an independent investigator.

< Prev Next > Page 1 of 95